
India has found violations related to manufacturing and laboratory practices at drugmaker Riemann Labs, whose cough syrup was linked to child deaths in Cameroon, a government health official told Reuters on Wednesday. Riemann Labs is the fourth Indian cough syrup maker to stop production after regulators found lapses.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2LiCZH8
via
IFTTT
0 comments:
Post a Comment